Literature DB >> 19403678

Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein.

Eric C Freundt1, Li Yu, Elizabeth Park, Michael J Lenardo, Xiao-Ning Xu.   

Abstract

Viruses such as hepatitis C and the severe acute respiratory syndrome coronavirus (SARS-CoV) encode proteins that are distributed between mitochondria and the nucleus, but little is known about the factors that control partitioning between these sites. SARS-CoV encodes a unique accessory gene called open reading frame (ORF) 3b that, like other unique accessory genes in SARS-CoV, likely contributes to viral pathogenicity. The ORF 3b protein is 154 amino acids and is predicted to express from the second ORF in subgenomic RNA3. In this report, we have characterized the molecular components that regulate intracellular localization of the ORF 3b protein. We demonstrate unique shuttling behavior of ORF 3b, whereby the protein initially accumulates in the nucleus and subsequently translocates to mitochondria. Following nuclear localization, ORF 3b traffics to the outer membrane of mitochondria via a predicted amphipathic alpha-helix. Additionally, ORF 3b contains a consensus nuclear export sequence, and we demonstrate that nuclear export and thus mitochondrial translocation are dependent on a leptomycin B-sensitive nuclear export mechanism. We further show that ORF 3b inhibits induction of type I interferon induced by retinoic acid-induced gene 1 and the mitochondrial antiviral signaling protein. Our observations provide insights into the cellular localization of ORF 3b that may enhance our understanding of the mechanisms by which ORF 3b contributes to SARS-CoV pathogenesis. The findings reported here reveal that for multilocalized proteins, consideration of the spatiotemporal distribution may be crucial for understanding viral protein behavior and function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19403678      PMCID: PMC2698541          DOI: 10.1128/JVI.00367-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Exportin-mediated nuclear export of proteins and ribonucleoproteins.

Authors:  Maarten Fornerod; Mutsuhito Ohno
Journal:  Results Probl Cell Differ       Date:  2002

2.  Characterization of a novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Paul A Rota; M Steven Oberste; Stephan S Monroe; W Allan Nix; Ray Campagnoli; Joseph P Icenogle; Silvia Peñaranda; Bettina Bankamp; Kaija Maher; Min-Hsin Chen; Suxiong Tong; Azaibi Tamin; Luis Lowe; Michael Frace; Joseph L DeRisi; Qi Chen; David Wang; Dean D Erdman; Teresa C T Peret; Cara Burns; Thomas G Ksiazek; Pierre E Rollin; Anthony Sanchez; Stephanie Liffick; Brian Holloway; Josef Limor; Karen McCaustland; Melissa Olsen-Rasmussen; Ron Fouchier; Stephan Günther; Albert D M E Osterhaus; Christian Drosten; Mark A Pallansch; Larry J Anderson; William J Bellini
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

3.  Virology. The SARS coronavirus: a postgenomic era.

Authors:  Kathryn V Holmes; Luis Enjuanes
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

4.  The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function.

Authors:  James S Gibbs; Daniela Malide; Felicita Hornung; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Characterization of a CRM1-dependent nuclear export signal in the C terminus of herpes simplex virus type 1 tegument protein UL47.

Authors:  Paul Williams; Janneke Verhagen; Gillian Elliott
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

6.  A novel influenza A virus mitochondrial protein that induces cell death.

Authors:  W Chen; P A Calvo; D Malide; J Gibbs; U Schubert; I Bacik; S Basta; R O'Neill; J Schickli; P Palese; P Henklein; J R Bennink; J W Yewdell
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

7.  Intracellular localization of the hepatitis B virus HBx protein.

Authors:  Frank Henkler; Jonathan Hoare; Naushin Waseem; Robert D Goldin; Michael J McGarvey; Rajen Koshy; Ian A King
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

8.  The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm.

Authors:  L Zheng; O Schickling; M E Peter; M J Lenardo
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

Review 9.  New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level.

Authors:  P Boya; B Roques; G Kroemer
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

10.  Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues.

Authors:  Donna M D'Agostino; Laura Ranzato; Giorgio Arrigoni; Ilaria Cavallari; Francesca Belleudi; Maria Rosaria Torrisi; Micol Silic-Benussi; Tiziana Ferro; Valeria Petronilli; Oriano Marin; Luigi Chieco-Bianchi; Paolo Bernardi; Vincenzo Ciminale
Journal:  J Biol Chem       Date:  2002-07-01       Impact factor: 5.157

View more
  54 in total

1.  Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus.

Authors:  Edward Emmott; Mark A Rodgers; Andrew Macdonald; Sarah McCrory; Paul Ajuh; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-05-13       Impact factor: 5.911

2.  The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein.

Authors:  Kanchan Bhardwaj; Pinghua Liu; Julian L Leibowitz; C Cheng Kao
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 3.  Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?

Authors:  Kavya Srinivasan; Ashutosh Kumar Pandey; Ashlena Livingston; Sundararajan Venkatesh
Journal:  Mol Biomed       Date:  2021-11-23

Review 4.  Continuous and Discontinuous RNA Synthesis in Coronaviruses.

Authors:  Isabel Sola; Fernando Almazán; Sonia Zúñiga; Luis Enjuanes
Journal:  Annu Rev Virol       Date:  2015-11       Impact factor: 10.431

5.  Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Authors:  Olivia Perwitasari; Scott Johnson; Xiuzhen Yan; Elizabeth Howerth; Sharon Shacham; Yosef Landesman; Erkan Baloglu; Dilara McCauley; Sharon Tamir; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

6.  Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.

Authors:  Keshav K Singh; Gyaneshwer Chaubey; Jake Y Chen; Prashanth Suravajhala
Journal:  Am J Physiol Cell Physiol       Date:  2020-06-08       Impact factor: 4.249

Review 7.  Functions of Coronavirus Accessory Proteins: Overview of the State of the Art.

Authors:  Puxian Fang; Liurong Fang; Huichang Zhang; Sijin Xia; Shaobo Xiao
Journal:  Viruses       Date:  2021-06-13       Impact factor: 5.048

Review 8.  Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians.

Authors:  Jeremy Chee; Woei Shyang Loh; Zheng Liu; Joaquim Mullol; De Yun Wang
Journal:  Curr Allergy Asthma Rep       Date:  2021-07-14       Impact factor: 4.806

Review 9.  Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.

Authors:  Ritesh Gorkhali; Prashanna Koirala; Sadikshya Rijal; Ashmita Mainali; Adesh Baral; Hitesh Kumar Bhattarai
Journal:  Bioinform Biol Insights       Date:  2021-06-22

10.  Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo.

Authors:  Trinayan Kashyap; Jackelyn Murray; Christopher J Walker; Hua Chang; Sharon Tamir; Bing Hou; Sharon Shacham; Michael G Kauffman; Ralph A Tripp; Yosef Landesman
Journal:  Antiviral Res       Date:  2021-06-19       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.